| 001 | 139838 | ||
| 005 | 20240321220708.0 | ||
| 024 | 7 | _ | |a 10.1093/brain/awx370 |2 doi |
| 024 | 7 | _ | |a pmid:29342275 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC5837483 |2 pmc |
| 024 | 7 | _ | |a 0006-8950 |2 ISSN |
| 024 | 7 | _ | |a 1460-2156 |2 ISSN |
| 024 | 7 | _ | |a altmetric:31582036 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-06160 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Brenner, David |b 0 |
| 245 | _ | _ | |a Hot-spot KIF5A mutations cause familial ALS. |
| 260 | _ | _ | |a Oxford |c 2018 |b Oxford Univ. Press |
| 264 | _ | 1 | |3 online |2 Crossref |b Oxford University Press (OUP) |c 2018-01-12 |
| 264 | _ | 1 | |3 print |2 Crossref |b Oxford University Press (OUP) |c 2018-03-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1631197322_23921 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a Heterozygous missense mutations in the N-terminal motor or coiled-coil domains of the kinesin family member 5A (KIF5A) gene cause monogenic spastic paraplegia (HSP10) and Charcot-Marie-Tooth disease type 2 (CMT2). Moreover, heterozygous de novo frame-shift mutations in the C-terminal domain of KIF5A are associated with neonatal intractable myoclonus, a neurodevelopmental syndrome. These findings, together with the observation that many of the disease genes associated with amyotrophic lateral sclerosis disrupt cytoskeletal function and intracellular transport, led us to hypothesize that mutations in KIF5A are also a cause of amyotrophic lateral sclerosis. Using whole exome sequencing followed by rare variant analysis of 426 patients with familial amyotrophic lateral sclerosis and 6137 control subjects, we detected an enrichment of KIF5A splice-site mutations in amyotrophic lateral sclerosis (2/426 compared to 0/6137 in controls; P = 4.2 × 10-3), both located in a hot-spot in the C-terminus of the protein and predicted to affect splicing exon 27. We additionally show co-segregation with amyotrophic lateral sclerosis of two canonical splice-site mutations in two families. Investigation of lymphoblast cell lines from patients with KIF5A splice-site mutations revealed the loss of mutant RNA expression and suggested haploinsufficiency as the most probable underlying molecular mechanism. Furthermore, mRNA sequencing of a rare non-synonymous missense mutation (predicting p.Arg1007Gly) located in the C-terminus of the protein shortly upstream of the splice donor of exon 27 revealed defective KIF5A pre-mRNA splicing in respective patient-derived cell lines owing to abrogation of the donor site. Finally, the non-synonymous single nucleotide variant rs113247976 (minor allele frequency = 1.00% in controls, n = 6137), also located in the C-terminal region [p.(Pro986Leu) in exon 26], was significantly enriched in familial amyotrophic lateral sclerosis patients (minor allele frequency = 3.40%; P = 1.28 × 10-7). Our study demonstrates that mutations located specifically in a C-terminal hotspot of KIF5A can cause a classical amyotrophic lateral sclerosis phenotype, and underline the involvement of intracellular transport processes in amyotrophic lateral sclerosis pathogenesis. |
| 536 | _ | _ | |a 344 - Clinical and Health Care Research (POF3-344) |0 G:(DE-HGF)POF3-344 |c POF3-344 |f POF III |x 0 |
| 542 | _ | _ | |i 2018-01-12 |2 Crossref |u http://creativecommons.org/licenses/by-nc/4.0/ |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a KIF5A protein, human |2 NLM Chemicals |
| 650 | _ | 7 | |a RNA, Messenger |2 NLM Chemicals |
| 650 | _ | 7 | |a Kinesin |0 EC 3.6.4.4 |2 NLM Chemicals |
| 650 | _ | 2 | |a Kinesins: genetics |2 MeSH |
| 650 | _ | 2 | |a Adult |2 MeSH |
| 650 | _ | 2 | |a Aged |2 MeSH |
| 650 | _ | 2 | |a Amyotrophic Lateral Sclerosis: genetics |2 MeSH |
| 650 | _ | 2 | |a DNA Mutational Analysis |2 MeSH |
| 650 | _ | 2 | |a Family Health |2 MeSH |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Genetic Association Studies |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Kinesin: genetics |2 MeSH |
| 650 | _ | 2 | |a Lymphocytes: drug effects |2 MeSH |
| 650 | _ | 2 | |a Lymphocytes: metabolism |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Middle Aged |2 MeSH |
| 650 | _ | 2 | |a Mutation: genetics |2 MeSH |
| 650 | _ | 2 | |a RNA, Messenger: genetics |2 MeSH |
| 650 | _ | 2 | |a RNA, Messenger: metabolism |2 MeSH |
| 700 | 1 | _ | |a Yilmaz, Rüstem |b 1 |
| 700 | 1 | _ | |a Müller, Kathrin |b 2 |
| 700 | 1 | _ | |a Grehl, Torsten |b 3 |
| 700 | 1 | _ | |a Petri, Susanne |b 4 |
| 700 | 1 | _ | |a Meyer, Thomas |b 5 |
| 700 | 1 | _ | |a Grosskreutz, Julian |b 6 |
| 700 | 1 | _ | |a Weydt, Patrick |0 P:(DE-HGF)0 |b 7 |
| 700 | 1 | _ | |a Ruf, Wolfgang |0 P:(DE-2719)9001522 |b 8 |u dzne |
| 700 | 1 | _ | |a Neuwirth, Christoph |b 9 |
| 700 | 1 | _ | |a Weber, Markus |b 10 |
| 700 | 1 | _ | |a Pinto, Susana |b 11 |
| 700 | 1 | _ | |a Claeys, Kristl G |b 12 |
| 700 | 1 | _ | |a Schrank, Berthold |b 13 |
| 700 | 1 | _ | |a Jordan, Berit |b 14 |
| 700 | 1 | _ | |a Knehr, Antje |b 15 |
| 700 | 1 | _ | |a Günther, Kornelia |b 16 |
| 700 | 1 | _ | |a Hübers, Annemarie |0 P:(DE-HGF)0 |b 17 |
| 700 | 1 | _ | |a Zeller, Daniel |b 18 |
| 700 | 1 | _ | |a Kubisch, Christian |b 19 |
| 700 | 1 | _ | |a Jablonka, Sibylle |b 20 |
| 700 | 1 | _ | |a Sendtner, Michael |b 21 |
| 700 | 1 | _ | |a Klopstock, Thomas |0 P:(DE-2719)2810704 |b 22 |
| 700 | 1 | _ | |a de Carvalho, Mamede |b 23 |
| 700 | 1 | _ | |a Sperfeld, Anne |b 24 |
| 700 | 1 | _ | |a Borck, Guntram |b 25 |
| 700 | 1 | _ | |a Volk, Alexander E |b 26 |
| 700 | 1 | _ | |a Dorst, Johannes |b 27 |
| 700 | 1 | _ | |a Weis, Joachim |b 28 |
| 700 | 1 | _ | |a Otto, Markus |b 29 |
| 700 | 1 | _ | |a Schuster, Joachim |b 30 |
| 700 | 1 | _ | |a Del Tredici, Kelly |b 31 |
| 700 | 1 | _ | |a Braak, Heiko |b 32 |
| 700 | 1 | _ | |a Danzer, Karin M |0 P:(DE-2719)9001513 |b 33 |u dzne |
| 700 | 1 | _ | |a Freischmidt, Axel-Dieter |0 P:(DE-2719)9001054 |b 34 |u dzne |
| 700 | 1 | _ | |a Meitinger, Thomas |0 P:(DE-2719)9000207 |b 35 |u dzne |
| 700 | 1 | _ | |a Strom, Tim M |b 36 |
| 700 | 1 | _ | |a Ludolph, Albert |0 P:(DE-2719)2812633 |b 37 |u dzne |
| 700 | 1 | _ | |a Andersen, Peter M |b 38 |
| 700 | 1 | _ | |a Weishaupt, Jochen H |0 P:(DE-2719)9000455 |b 39 |e Corresponding author |u dzne |
| 700 | 1 | _ | |a MND-NET, German ALS network |b 40 |
| 700 | 1 | _ | |a Weyen, Ute |b 41 |
| 700 | 1 | _ | |a Hermann, Andreas |0 P:(DE-2719)2811732 |b 42 |u dzne |
| 700 | 1 | _ | |a Hagenacker, Tim |b 43 |
| 700 | 1 | _ | |a Koch, Jan Christoph |b 44 |
| 700 | 1 | _ | |a Lingor, Paul |0 P:(DE-2719)2812561 |b 45 |u dzne |
| 700 | 1 | _ | |a Göricke, Bettina |b 46 |
| 700 | 1 | _ | |a Zierz, Stephan |b 47 |
| 700 | 1 | _ | |a Baum, Petra |b 48 |
| 700 | 1 | _ | |a Wolf, Joachim |b 49 |
| 700 | 1 | _ | |a Winkler, Andrea |b 50 |
| 700 | 1 | _ | |a Young, Peter |b 51 |
| 700 | 1 | _ | |a Bogdahn, Ulrich |b 52 |
| 700 | 1 | _ | |a Prudlo, Johannes |0 P:(DE-2719)2380559 |b 53 |u dzne |
| 700 | 1 | _ | |a Kassubek, Jan |b 54 |
| 773 | 1 | 8 | |a 10.1093/brain/awx370 |b : Oxford University Press (OUP), 2018-01-12 |n 3 |p 688-697 |3 journal-article |2 Crossref |t Brain |v 141 |y 2018 |x 0006-8950 |
| 773 | _ | _ | |a 10.1093/brain/awx370 |g Vol. 141, no. 3, p. 688 - 697 |0 PERI:(DE-600)1474117-9 |n 3 |q 141:3<688 - 697 |p 688-697 |t Brain |v 141 |y 2018 |x 0006-8950 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5837483 |
| 909 | C | O | |p VDB |o oai:pub.dzne.de:139838 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 8 |6 P:(DE-2719)9001522 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 22 |6 P:(DE-2719)2810704 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 33 |6 P:(DE-2719)9001513 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 34 |6 P:(DE-2719)9001054 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 35 |6 P:(DE-2719)9000207 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 37 |6 P:(DE-2719)2812633 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 39 |6 P:(DE-2719)9000455 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 42 |6 P:(DE-2719)2811732 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 45 |6 P:(DE-2719)2812561 |
| 910 | 1 | _ | |a External Institute |0 I:(DE-HGF)0 |k Extern |b 53 |6 P:(DE-2719)2380559 |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-344 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Clinical and Health Care Research |x 0 |
| 914 | 1 | _ | |y 2018 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2022-11-09 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2022-11-09 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b BRAIN : 2021 |d 2022-11-09 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2022-11-09 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2022-11-09 |
| 915 | _ | _ | |a IF >= 15 |0 StatID:(DE-HGF)9915 |2 StatID |b BRAIN : 2021 |d 2022-11-09 |
| 920 | 1 | _ | |0 I:(DE-2719)1111016 |k Clinical Dementia Research München |l Clinical Dementia Research München |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1111016 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |y 2005 |2 Crossref |o Andersen 2005 |
| 999 | C | 5 | |y 2012 |2 Crossref |o Andersen 2012 |
| 999 | C | 5 | |y 2013 |2 Crossref |o Braak 2013 |
| 999 | C | 5 | |y 2017 |2 Crossref |o Braak 2017 |
| 999 | C | 5 | |y 2016 |2 Crossref |o Brenner 2016 |
| 999 | C | 5 | |y 2014 |2 Crossref |o Brettschneider 2014 |
| 999 | C | 5 | |y 2002 |2 Crossref |o Celniker 2002 |
| 999 | C | 5 | |y 2009 |2 Crossref |o Chiò 2009 |
| 999 | C | 5 | |y 2011 |2 Crossref |o Deng 2011 |
| 999 | C | 5 | |y 2016 |2 Crossref |o Duis 2016 |
| 999 | C | 5 | |y 2014 |2 Crossref |o Fagerberg 2014 |
| 999 | C | 5 | |y 1994 |2 Crossref |o Figlewicz 1994 |
| 999 | C | 5 | |y 2015 |2 Crossref |o Freischmidt 2015 |
| 999 | C | 5 | |y 2008 |2 Crossref |o Gitcho 2008 |
| 999 | C | 5 | |y 2009 |2 Crossref |o Goizet 2009 |
| 999 | C | 5 | |y 2004 |2 Crossref |o Gros-Louis 2004 |
| 999 | C | 5 | |y 2017 |2 Crossref |o Guinto 2017 |
| 999 | C | 5 | |y 2013 |2 Crossref |o Herder 2013 |
| 999 | C | 5 | |y 2009 |2 Crossref |o Hirokawa 2009 |
| 999 | C | 5 | |y 2016 |2 Crossref |o Kaji 2016 |
| 999 | C | 5 | |y 2016 |2 Crossref |o Kenna 2016 |
| 999 | C | 5 | |y 2008 |2 Crossref |o Kimonis 2008 |
| 999 | C | 5 | |y 2008 |2 Crossref |o Kühnlein 2008 |
| 999 | C | 5 | |y 2016 |2 Crossref |o Lek 2016 |
| 999 | C | 5 | |y 2001 |2 Crossref |o Livak 2001 |
| 999 | C | 5 | |y 2014 |2 Crossref |o Liu 2014 |
| 999 | C | 5 | |y 2017 |2 Crossref |o McLaughlin 2017 |
| 999 | C | 5 | |y 2017 |2 Crossref |o Morais 2017 |
| 999 | C | 5 | |y 2012 |2 Crossref |o Nakajima 2012 |
| 999 | C | 5 | |y 2018 |2 Crossref |o Nguyen 2018 |
| 999 | C | 5 | |y 1994 |2 Crossref |o Niclas 1994 |
| 999 | C | 5 | |y 2009 |2 Crossref |o Örlén 2009 |
| 999 | C | 5 | |y 2003 |2 Crossref |o Puls 2003 |
| 999 | C | 5 | |y 2013 |2 Crossref |o Randall 2013 |
| 999 | C | 5 | |y 2002 |2 Crossref |o Reid 2002 |
| 999 | C | 5 | |y 2017 |2 Crossref |o Rydzanicz 2017 |
| 999 | C | 5 | |y 2014 |2 Crossref |o Smith 2014 |
| 999 | C | 5 | |y 2013 |2 Crossref |o Tan 2013 |
| 999 | C | 5 | |y 2012 |2 Crossref |o Van Blitterswijk 2012 |
| 999 | C | 5 | |y 2010 |2 Crossref |o Wang 2010 |
| 999 | C | 5 | |y 2012 |2 Crossref |o Wu 2012 |
| 999 | C | 5 | |y 2001 |2 Crossref |o Yang 2001 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|